PHARMACYTE BIOTECH, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
PHARMACYTE BIOTECH, INC. (PMCB) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $78.38 thousand for the 12-month period ending 2025-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-07-29
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $78.38K, a 1.98% increase from fiscal 2024.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $76.86K, a 81.02% decline from fiscal 2023.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $405.06K, a 79.50% decline from fiscal 2022.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $1.98M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-04-30 | $78.38K 10-K · filed 2026-07-29 |
| 2024-04-30 | $76.86K 10-K · filed 2025-08-11 |
| 2023-04-30 | $405.06K 10-K · filed 2024-08-13 |
| 2022-04-30 | $1.98M 10-K · filed 2023-07-31 |
| 2021-04-30 | $0.00 10-K · filed 2022-07-28 |
| 2019-04-30 | $0.00 10-K · filed 2019-08-13 |
| 2018-04-30 | -$20.39K 10-K · filed 2019-08-13 |
| 2017-04-30 | -$20.39K 10-K · filed 2018-07-20 |
| 2016-04-30 | -$2.07M 10-K · filed 2017-07-27 |
| 2015-04-30 | $0.00 10-K · filed 2016-07-29 |
| 2014-04-30 | $0.00 10-K · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |